# US 2024/0067997 A1 · Genomic engineering of biosynthetic pathways leading to increased nadph

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0067997 A1
- Document ID: US20240067997A1
- Status: Published application
- Kind: A1
- Application number: 18/045,098
- Filed: 2022-10-07
- Published: 2024-02-29
- Earliest claimed: 2017-05-19
- Assignees: Zymergen Inc.
- Applicants: Zymergen Inc.
- Inventors: Shawn MANCHESTER; Benjamin MASON; Alexi GORANOV
- Web page: https://patentgrep.com/patent/US20240067997A1

## CPC

- C12P 13/08: Lysine; Diaminopimelic acid; Threonine; Valine
- C12P 19/36: Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate
- C12Y 117/01: with NAD+ or NADP+ as acceptor (1.17.1)
- C12Y 102/01011: Aspartate-semialdehyde dehydrogenase (1.2.1.11)
- C12Y 102/01012: Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)
- C12Y 104/01003: Glutamate dehydrogenase (NAD(P)+)(1.4.1.3)
- C12Y 105/01017: Alanopine dehydrogenase (1.5.1.17)
- C12Y 401/02042: D-Threonine aldolase (4.1.2.42)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The disclosure relates to host cells having altered NADPH availability, allowing for increased production of compounds produced using NADPH, and methods of use thereof. NADPH availability is altered by one or more of: expressing an altered GAPDH, expressing a variant glutamate dehydrogenase (gdh), aspartate semialdehyde dehydrogenase (asd), dihydropicolinate reductase (dapB), and meso-diaminopimelate dehydrogenase (ddh), expressing a novel nicotinamide nucleotide transhydrogenase, expressing a novel threonine aldolase, and expressing or modulating the expression of a pyruvate carboxylase in the host cells.

## Claims

### Claim at position 1

-76. (canceled)

### Claim 77

A recombinant microbial cell comprising:
a) an aldehyde dehydrogenase comprising an amino acid sequence that is at least 70% identical to SEQ ID NO: 30 or an aspartate-semi-aldehyde dehydrogenase comprising an amino acid sequence that is at least 70% identical to SEQ ID NO:40;
b) a glutamate dehydrogenase comprising an amino acid sequence that is at least 70% identical to SEQ ID NO: 44;
c) a 4-hydroxy-tetrahydrodipicolinate reductase comprising an amino acid sequence that is at least 70% identical to SEQ ID NO: 48; and
d) a meso-diaminopimelate D-dehydrogenase comprising an amino acid sequence that is at least 70% identical to SEQ ID NO: 4.

### Claim 78 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell produces more L-Lysine than a microbial cell that does not contain a)-d).

### Claim 79 (depends on 78)

The microbial cell of claim 78, wherein the microbial cell produces at least 40% more L-Lysine than a microbial cell that does not contain a)-d).

### Claim 80 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell is a Bacillus cell.

### Claim 81 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell is a Geobacillus cell.

### Claim 82 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell is a Corynebacterium cell.

### Claim 83 (depends on 82)

The microbial cell of claim 82, wherein the microbial cell is a Corynebacterium glutamicum cell.

### Claim 84 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell is an Escherichia cell.

### Claim 85 (depends on 84)

The microbial cell of claim 84, wherein the microbial cell is an Escherichia coli cell.

### Claim 86 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell further expresses a pyruvate carboxylase (pyc).

### Claim 87 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell comprises SEQ ID NO: 30.

### Claim 88 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell comprises SEQ ID NO: 40.

### Claim 89 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell comprises SEQ ID NO: 44.

### Claim 90 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell comprises SEQ ID NO: 48.

### Claim 91 (depends on 77)

The microbial cell of claim 77, wherein the microbial cell comprises SEQ ID NO: 4.

### Claim 92 (depends on 77)

The microbial cell of claim 77, wherein the aldehyde dehydrogenase has an amino acid that is at least 90% identical to SEQ ID NO: 30.

### Claim 93 (depends on 77)

The microbial cell of claim 77, wherein the aspartate-semi-aldehyde dehydrogenase has an amino acid sequence that is at least 90% identical to SEQ ID NO:40.

### Claim 94 (depends on 77)

The microbial cell of claim 77, wherein the glutamate dehydrogenase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 44.

### Claim 95 (depends on 77)

The microbial cell of claim 77, wherein the 4-hydroxy-tetrahydrodipicolinate reductase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 48.

### Claim 96 (depends on 77)

The microbial cell of claim 77, wherein the meso-diaminopimelate D-dehydrogenase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 4.
